Page last updated: 2024-10-20

uric acid and Follicular Thyroid Carcinoma

uric acid has been researched along with Follicular Thyroid Carcinoma in 1 studies

Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.

Research Excerpts

ExcerptRelevanceReference
"Ionizing radiation in differentiated thyroid cancer (DTC) patients treated with radioiodine (131-I) produces reactive oxygen species (ROS), which could induce oxidative stress with disturbance of redox balance."1.40Oxidative stress in patients with differentiated thyroid cancer: early effects of radioiodine therapy. ( Djukic, SM; Jovanovic, MD; Radivojevic, SD; Simonovic, ST; Teodorovic, LC; Vrndic, OB, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vrndic, OB1
Radivojevic, SD1
Jovanovic, MD1
Djukic, SM1
Teodorovic, LC1
Simonovic, ST1

Other Studies

1 other study available for uric acid and Follicular Thyroid Carcinoma

ArticleYear
Oxidative stress in patients with differentiated thyroid cancer: early effects of radioiodine therapy.
    Indian journal of biochemistry & biophysics, 2014, Volume: 51, Issue:3

    Topics: Adenocarcinoma, Follicular; Antioxidants; Carcinoma, Papillary; Case-Control Studies; Female; Humans

2014